Literature DB >> 21715329

Crystal structure of the E2 domain of amyloid precursor protein-like protein 1 in complex with sucrose octasulfate.

Yi Xue1, Sangwon Lee, Yongcheng Wang, Ya Ha.   

Abstract

Missense mutations in the amyloid precursor protein (APP) gene can cause familial Alzheimer disease. It is thought that APP and APP-like proteins (APLPs) may play a role in adhesion and signal transduction because their ectodomains interact with components of the extracellular matrix. Heparin binding induces dimerization of APP and APLPs. To help explain how these proteins interact with heparin, we have determined the crystal structure of the E2 domain of APLP1 in complex with sucrose octasulfate (SOS). A total of three SOS molecules are bound to the E2 dimer. Two SOSs are bound inside a narrow intersubdomain groove, and the third SOS is bound near the two-fold axis of the protein. Mutational analyses show that most residues interacting with SOS also contribute to heparin binding, although in varying degrees; a deep pocket, defined by His-376, Lys-422, and Arg-429, and an interfacial site between Lys-314 and its symmetry mate are most important in the binding of the negatively charged polysaccharide. Comparison with a lower resolution APP structure shows that all key heparin binding residues are conserved and identically positioned, suggesting that APLP1 and APP may bind heparin similarly. In transfected HEK-293 cells, mutating residues responsible for heparin binding causes little change in the proteolysis of APP by the secretases. However, mutating a pair of conserved basic residues (equivalent to Arg-414 and Arg-415 of APLP1) immediately adjacent to the heparin binding site affects both the maturation and the processing of APP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715329      PMCID: PMC3191016          DOI: 10.1074/jbc.M111.219659

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

2.  Macromolecular TLS refinement in REFMAC at moderate resolutions.

Authors:  Martyn D Winn; Garib N Murshudov; Miroslav Z Papiz
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

3.  sAPP as a regulator of dendrite motility and melanin release in epidermal melanocytes and melanoma cells.

Authors:  Thomas Quast; Sven Wehner; Gregor Kirfel; Klaus Jaeger; Michele De Luca; Volker Herzog
Journal:  FASEB J       Date:  2003-07-03       Impact factor: 5.191

4.  Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members.

Authors:  S Heber; J Herms; V Gajic; J Hainfellner; A Aguzzi; T Rülicke; H von Kretzschmar; C von Koch; S Sisodia; P Tremml; H P Lipp; D P Wolfer; U Müller
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

5.  The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement.

Authors:  S L Sabo; A F Ikin; J D Buxbaum; P Greengard
Journal:  J Cell Biol       Date:  2001-06-25       Impact factor: 10.539

Review 6.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

7.  Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

Authors:  P Seubert; C Vigo-Pelfrey; F Esch; M Lee; H Dovey; D Davis; S Sinha; M Schlossmacher; J Whaley; C Swindlehurst
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

Review 8.  Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders.

Authors:  Jack van Horssen; Pieter Wesseling; Lambert P W J van den Heuvel; Robert M W de Waal; Marcel M Verbeek
Journal:  Lancet Neurol       Date:  2003-08       Impact factor: 44.182

9.  Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor.

Authors:  W Wasco; K Bupp; M Magendantz; J F Gusella; R E Tanzi; F Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase.

Authors:  Zoe Scholefield; Edwin A Yates; Gareth Wayne; Augustin Amour; William McDowell; Jeremy E Turnbull
Journal:  J Cell Biol       Date:  2003-10-06       Impact factor: 10.539

View more
  5 in total

1.  Crystal structure of amyloid precursor-like protein 1 and heparin complex suggests a dual role of heparin in E2 dimerization.

Authors:  Yi Xue; Sangwon Lee; Ya Ha
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  SorLA complement-type repeat domains protect the amyloid precursor protein against processing.

Authors:  Arnela Mehmedbasic; Sofie K Christensen; Jonas Nilsson; Ulla Rüetschi; Camilla Gustafsen; Annemarie Svane Aavild Poulsen; Rikke W Rasmussen; Anja N Fjorback; Göran Larson; Olav M Andersen
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

Review 3.  Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease.

Authors:  Edgar Dawkins; David H Small
Journal:  J Neurochem       Date:  2014-03-07       Impact factor: 5.372

4.  The crystal structure of DR6 in complex with the amyloid precursor protein provides insight into death receptor activation.

Authors:  Kai Xu; Olav Olsen; Dorothea Tzvetkova-Robev; Marc Tessier-Lavigne; Dimitar B Nikolov
Journal:  Genes Dev       Date:  2015-04-02       Impact factor: 11.361

5.  Docking server for the identification of heparin binding sites on proteins.

Authors:  Scott E Mottarella; Dmitri Beglov; Natalia Beglova; Matthew A Nugent; Dima Kozakov; Sandor Vajda
Journal:  J Chem Inf Model       Date:  2014-07-10       Impact factor: 4.956

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.